Quince Therapeutics
QNCX
#11264
Rank
ยฃ0.68 M
Marketcap
ยฃ0.70
Share price
-2.43%
Change (1 day)
-49.05%
Change (1 year)

Earnings for Quince Therapeutics (QNCX)

Earnings in 2026 (TTM): -ยฃ45.57 Million

According to Quince Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -ยฃ38.19 Million a decrease over its 2024 earnings that were of -ยฃ27.39 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Quince Therapeutics from 2018 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ45.57 Million19.33%
2025 -ยฃ38.19 Million39.42%
2024 -ยฃ27.39 Million33.58%
2023 -ยฃ20.51 Million-47.15%
2022 -ยฃ38.8 Million-43.27%
2021 -ยฃ68.4 Million17.53%
2020 -ยฃ58.2 Million99.1%
2019 -ยฃ29.23 Million235.08%
2018 -ยฃ8.73 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-ยฃ0.12 Billion 156.81%๐Ÿ‡บ๐Ÿ‡ธ USA